Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-05-28 @ 8:57 PM
Study NCT ID:
NCT00522132
Status:
COMPLETED
Last Update Posted:
2011-09-16
First Post:
2007-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Artesunate Study in Severe Malaria
Sponsor:
Medicines for Malaria Venture
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EDCTP/MMV07-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jörg J. Möhrle
Old Organization:
Medicines for Malaria Venture